Nu Skin Joins Forces With Toyo Bio Pharma

July 29, 2008 | By Monika Mundell |


Nu Skin has signed a memorandum to join forces with a Toyo Bio Pharma (a subsidiary of Toyo Shinyaku). Toyo Bio Pharma is a natural products manufacturer with facilities in the United States and Japan. The two companies intend to engage into a joint research and development relationship together.

Nu Skin is the first company in the direct selling industry to come to such an agreement with with Toyo Bio-Pharma. The companies’ collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network.

Yoshi Shiraishi, president and CEO of Toyo Bio-Pharma said "We expect this relationship with Nu Skin Enterprises to nicely complement our current expertise in natural health supplements. We highly respect the industry-leading research and development capabilities of Nu Skin Enterprises. We believe there is a synergy between the two research teams that both companies can benefit from."

"Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku, which is one of the most reputable supplement and skin care manufacturers in Japan, and we look forward to developing a robust relationship with joint development opportunities," said Joseph Chang, Ph. D., chief scientific officer and executive vice president of product development at Nu Skin Enterprises. "We are eager to leverage their knowledge of navigating regulatory requirements for skin care and supplements in Japan."

Tags: , , , ,

Related Posts:

RSS feed | Trackback URI

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
URI
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.